# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Novo Nordisk, Carvana, And Now Rivian We've had bullish moves in three stocks we had bullish bets on this week, and since...
Carvana's stock notched a new 52-week high Wednesday, and the stock is up more than 18% over the past month. Here's a l...
Wedbush analyst Seth Basham reiterates Carvana (NYSE:CVNA) with a Neutral and maintains $120 price target.
Needham analyst Chris Pierce reiterates Carvana (NYSE:CVNA) with a Hold.